DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20212085

Association between vitamin B12 and non-alcoholic fatty liver disease: a case control study in Katra Jammu

Chandan Sharma, Ashima Badyal

Abstract


Background: Non-alcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease in developed countries and obesity contributing maximum to the disease load. A reduction in the energy content of diet, alone, may not prevent NAFLD, nor could alleviate it. Recent studies are bringing to light the association, importance and role of dietary vitamins and liver fat accumulation. Vitamin B12 is involved in the metabolism of every cell of the human body. It is a cofactor in DNA synthesis and in both fatty acid and amino acid metabolism. Still, the influence of vitamin B12 deficiency on NAFLD has not been studied much.

Methods: A case control observational study was conducted in the department of medicine, community health center, Katra during the period of August 2018 to July 2019. The study was conducted on 150 NAFLD patients and 50 aged and gender-matched healthy controls. Patients showing ethanol consumption, liver cirrhosis, DM, pancreatitis, renal failure or cancer were excluded.

Results: Patients and controls almost matched in all clinical examinations like fever, jaundice, nausea, but vitamin B12 levels were significantly low among cases and stood at 377.60±181.43 pg/ml as against 548.28±285.70 for controls, but still remained within the reference range. Vitamin D levels were also found to be lower among cases. B12 deficiency is extremely common in India with an estimated prevalence of 47% and more males tend to have NAFLD than females.

Conclusions: For better management of the disease, vitamin B12 levels should be assessed in all NAFLD patients.


Keywords


Vitamin B12, Non-alcoholic fatty liver disease, Obesity, Vitamin D

Full Text:

PDF

References


Caldwell SH, Crespo DM. The spectrum expanded: cryptogenic cirrhosis and the natural history of non- alcoholic fatty liver disease. J Hepatol. 2004;40(4):578-84.

Pappachan JM, Babu S, Krishnan B, Ravindran NC. Non-alcoholic fatty liver disease: a clinical update. J Clin Transl Hepatol. 2017;5(4):384-93.

Nassir F, Rector RS, Hammoud GM, Ibdah JA. Pathogenesis and prevention of hepatic steatosis. Gastroenterol Hepatol (N Y). 2015;11(3):167-75.

Bataller R, Rombouts K, Altamirano J, Marra F. Fibrosis in alcoholic and nonalcoholic steatohepatitis. Best Pract Res Clin Gastroenterol. 2011;25(2):231-44.

Ge X, Zheng L, Wang M, Du Y, Jiang J. Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990-2017: a population-based observational study. BMJ Open. 2020;10(8).

Green R, Miller JW. Vitamin B12. In: Zemplini J, Rucker RB, Suttie JW, McCormick DB, eds. Handbook of vitamins. 2nd ed. Boca Raton, FL: CRC Press; 2007: 413-57.

Yamada K. (2013). Cobalt: its role in health and disease. Met Ions Life Sci. 2013;13:295-320.

Lieberman M, Marks AD. Tetrahydrofolate, vitamin B12 and S-adenosylmethionine. In: Lieberman M, Marks AD, eds. Mark's basic medical biochemistry: a clinical approach. 3rd ed. Philadelphia, PA: Wolters Kluwer/Lippincott Willaims and Wilkins; 2009.

Institute of medicine (US) standing committee on the scientific evaluation of dietary reference intakes and its panel on folate, other B vitamins, and choline. Dietary reference intakes: thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, DC: National Academy Press; 1998.

Koplay M, Gulcan E, Ozkan F. Association between serum vitamin B12 levels and the degree of steatosis in patients with nonalcoholic fatty liver disease. J Investig Med. 2011;59(7):1137-40.

Cylwik B, Czygier M, Daniluk M, Chrostek L, Szmitkowski M. Vitamin B12 concentration in the blood of alcoholics. Pol Merkur Lekarski. 2010;28(164):122-5.

Sasidharan PK. B12 deficiency in India. Arch Med Health Sci. 2017;5(2):261-8.

Singla R, Garg A, Surana V, Aggarwal S, Gupta G, Singla S. Vitamin B12 deficiency is endemic in indian population: a perspective from North India. Indian J Endocrin Metab. 2019;23(2):211-4.

Allen LH. How common is vitamin B12 deficiency? Am J Clin Nutr. 2009;89(2):693-6.

Yang DT, Cook RJ. Spurious elevations of Vitamin B12 with pernicious anemia. N Engl J Med. 2012;366:1742-3.

Carmel R, Agrawal YP. Failures of cobalamin assays in pernicious anemia. N Engl J Med. 2012;367(4):385-6.

Stabler SP, Marcell PD, Podell ER, Allen RH, Lindenbaum J. Assay of methylmalonic acid in the serum of patients with cobalamin deficiency using capillary gas chromatography-mass spectrometry. J Clin Invest. 1986;77(5):1606-12.

Kavimandan A, Sharma M, Verma AK, et al. Prevalence of celiac disease in nutritional anemia at a tertiary care center.

Al-Quaydheb AN, Ofaysan MSB, Rasheed AAL. Relation between vitamin B12 and Non-alcoholic fatty liver disease: a hospital based study. Int J Adv Res. 2015;3(6):1335-43.

Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Digest Dis. 2010;28(1):155-61.

Foster T, Anania FA, Li D, Katz R, Budoff M. The prevalence and clinical correlates of nonalcoholic fatty liver disease (NAFLD) in African Americans: the multiethnic study of atherosclerosis (MESA). Digest Dis Sci. 2013;58(8):2392-8.

Polyzos SA, Kountouras J, Patsiaoura K, Katsiki E, Zafeiriadou E, Zavos C, et al. Serum vitamin B12 and folate levels in patients with non-alcoholic fatty liver disease. Int J Food Sci Nutr. 2012;63(6):659-66.

Hariri M, Zohdi S. Effect of Vitamin D on non-alcoholic fatty liver disease: a systematic review of randomized controlled clinical trials. Int J Prev Med. 2019;10:14.